Files

2024_Pierrard_Tech_Innov_Patient_Support_Radiat_Oncol_100277.pdf
  • Open Access
  • Adobe PDF
  • 2.23 MB
  • https://creativecommons.org/licenses/by-nc-nd/4.0/

Details

Authors
Abstract
INTRODUCTION: Intra- and inter-fraction rectum motion is important for pelvic radiotherapy (RT). This study assesses how RT session duration, the presence or the absence of an intra-rectal tumour, and the distance from the anorectal junction (ARJd) impact rectal motion. MATERIALS AND METHODS: Analyses used cone-beam computed tomographies (CBCTs) from RT patients treated for rectal and prostate cancer. Three structures were evaluated: (1) the entire rectum in patients without a rectal tumour (RectumProstate); (2) the non-invaded portion (RectumRectum) and (3) the tumour-invaded portion (RectumTumour) in rectal cancer patients.Intrafraction motion was assessed using the Hausdorff distance 95% and the Mean distance-to-agreement between structures delineated on the first CBCT and the 2 subsequent CBCTs within a same RT session. Interfraction motion was quantified by comparing structures delineated on the planning-CT and the first CBCT of each session.Linear mixed model evaluated rectum motion in relation to time, tumour presence, and ARJd, respectively. RESULTS: We included 10 patients with and 10 without rectal cancer, collecting 385 CBCTs. A significant correlation (p < 0.05) between rectum motion and RT session duration was found. Intrafraction motion was significantly higher in prostate cancer patients (RectumProstate motion > RectumRectum and RectumTumour, p < 0.01). For interfraction motion, only the mean distance to agreement was significantly higher for RectumProstate (p < 0.05). Motion increased significantly with ARJd for all three structures (p < 0.001). CONCLUSIONS: Session duration, absence of a tumour, and ARJd are associated with larger intra- and interfraction rectal motion. This highlights the need for tailored RT treatment, including online-adaptive RT, to manage intra- and interfraction variations. Rectal motion should be handled differently for patients with prostate cancer and those with rectal cancer.
Affiliations

Citations

Pierrard, J., Heylen, S., Vandermeulen, A., & Van Ooteghem, G. (2024). Dealing with rectum motion during radiotherapy: How can we anticipate it? Technical Innovations & Patient Support in Radiation Oncology, 32, 100277 [1-8]. https://doi.org/10.1016/j.tipsro.2024.100277 (Original work published 2024)